ANEB (STOCKS)
Anebulo Pharmaceuticals, Inc. Common Stock
$0.474700
-0.001300 (-0.27%)
Prev close: $0.476000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard Anthony Cunningham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $19.53M
- Employees
- 3
- P/E (TTM)
- -2.02
- P/B (TTM)
- 2.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q1)
|
$-0.05 | $-0.12 | +0.0724 | +59.15% |
|
Jun 2025 (Q4)
|
$-0.05 | $-0.08 | +0.0316 | +38.73% |
|
Mar 2025 (Q3)
|
$-0.04 | $-0.05 | +0.0110 | +21.57% |
|
Dec 2024 (Q2)
|
$-0.09 | $-0.08 | -0.0084 | -10.29% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $629.24K |
| Operating Expenses | $9.07M |
| Research and Development | $3.80M |
| Other Operating Expenses | $5.28M |
| Operating Income/Loss | -$9.07M |
| Income/Loss From Continuing Operations After Tax | -$8.44M |
| Income/Loss From Continuing Operations Before Tax | -$8.44M |
| Interest Expense, Operating | $317.00K |
| Net Income/Loss | -$8.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.23 |
| Diluted Earnings Per Share | -$0.23 |
| Basic Average Shares | 111,997,529 |
| Diluted Average Shares | 111,997,529 |
| Assets | $10.70M |
| Current Assets | $10.54M |
| Prepaid Expenses | $170.77K |
| Other Current Assets | $10.36M |
| Noncurrent Assets | $165.67K |
| Liabilities | $963.82K |
| Current Liabilities | $963.82K |
| Accounts Payable | $607.54K |
| Other Current Liabilities | $356.28K |
| Noncurrent Liabilities | $0.00 |
| Equity | $9.74M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.74M |
| Liabilities And Equity | $10.70M |
| Net Cash Flow From Operating Activities | -$5.93M |
| Net Cash Flow From Operating Activities, Continuing | -$5.93M |
| Net Cash Flow | $416.91K |
| Net Cash Flow, Continuing | $416.91K |
| Comprehensive Income/Loss | -$8.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.44M |
| Other Comprehensive Income/Loss | $0.00 |